Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: jack w garnes jr. who wrote (9987)	6/24/1998 2:54:00 PM
From: RT	Respond to of 23519

Jack, Why are you blaming the M.D.'s? You should know by now you can't trust doctors, lawyers, policeman and politicians. <<gg>> RT

To: jack w garnes jr. who wrote (9987)	6/24/1998 2:58:00 PM
From: DaiS	Read Replies (1) \| Respond to of 23519

I got this nice message from Astra From: Hans.Karlsson@astra.se.astra.com To: Subject: FW: Vivus-owner Date sent: Mon, 22 Jun 1998 12:56:32 +0200 > Dear > > Astra believes that there is room for more than one therapy against > impotence. Muse is one of the best and has a fair potential, even > when considering the successes of Viagra. > > We have introduced Muse in GB and in Sweden so far, and are in the > process of introducing it in the rest of Europe, New Zeeland, > Australia and Latin America. The order of these markets to start is > not set yet. > > The relationship between Vivus and FDA must be a topic for them to > comment on. > > Naturally, Astra will do everything to support Muse - as we do with > all our products - at introduction to a new market. Most of the > efforts is directed at convincing the prescribers of the exellent > therapy that Muse offers, but we also use advertizing and PR in this > work. > > > Yours sincerely, > > John Ahlmark > My E-mail requesting information said, From: To: infomaster@astra.se.astra.com Subject: Vivus Date sent: Tue, 16 Jun 1998 12:50:43 0000 Dear Sir, I am a shareholder in the American company Vivus. I understand that you have an interest in Vivus and are distributing muse in Europe and elsewhere. I have been very concerned recently about the decline in the share price of Vivus and the paucity of positive press releases about what I regard as a good product. I would be grateful if you could provide me with information regarding the following. 1. Does Astra believe that muse will be profitable given the pressure from viagra? 2. What volume of sales in terms of muse packs (6 units) does Astra hope to achieve this year and in 1999? 3. Which countries will you be selling muse in by end of this year? 4. Can you throw any light on the reason for the delay in FDA approval of the Vivus new plant? 5. Will Astra contribute to the dissemination of positive information through press and media on muse? Yours sincerely,

To: jack w garnes jr. who wrote (9987)	6/24/1998 3:26:00 PM
From: AlienTech	Respond to of 23519

>>I blame our down fall on the M.D.'s on this thread mainly ED..<<< Okay I'll get the rope, you get the electric pan. Lets fry his buns!